Darmiyan, Inc.

Darmiyan, Inc. is a healthcare technology company developing AI-based tools for brain health and Alzheimer’s disease risk assessment. Its BrainSee product is designed to use MRI and cognitive assessment data to help estimate whether a person with mild cognitive impairment may progress to Alzheimer’s disease dementia. Darmiyan reports that BrainSee received FDA Breakthrough Device Designation and was validated by third-party investigators.